TRUVERNA Trademark

Trademark Overview


On Tuesday, December 9, 2025, a trademark application was filed for TRUVERNA with the United States Patent and Trademark Office. The USPTO has given the TRUVERNA trademark a serial number of 99537251. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, March 16, 2026. This trademark is owned by Merck KGaA. The TRUVERNA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biological research; Clinical research in the field of pharmaceuticals; Medical research; Scientific research; Pharmaceutical research and development; Scientific and technological services, namely, preparation of reports in the field of scientific research; Research and development services in the field of antibodies; Scientific and technological services, namely, scientific research and testing in the field of bacteriology and virology; Research and development of vaccines and medicines; Development of pharmaceutical preparations and medicines; Scientific research in the nature of conducting clinical trials for others in the field of pharmaceuticals; Consulting services in the field of pharmaceutical research and development; Scientific study and research in the field(s) of pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research consulting; Pharmaceutical product evaluation; Genetic testing for sc...
truverna

General Information


Serial Number99537251
Word MarkTRUVERNA
Filing DateTuesday, December 9, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, March 16, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 7, 2026

Trademark Statements


Goods and ServicesBiological research; Clinical research in the field of pharmaceuticals; Medical research; Scientific research; Pharmaceutical research and development; Scientific and technological services, namely, preparation of reports in the field of scientific research; Research and development services in the field of antibodies; Scientific and technological services, namely, scientific research and testing in the field of bacteriology and virology; Research and development of vaccines and medicines; Development of pharmaceutical preparations and medicines; Scientific research in the nature of conducting clinical trials for others in the field of pharmaceuticals; Consulting services in the field of pharmaceutical research and development; Scientific study and research in the field(s) of pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research consulting; Pharmaceutical product evaluation; Genetic testing for scientific research purposes; Research and development in the field of gene therapy; Scientific and technological services, namely, testing in the field of antibodies; Scientific and technological services, namely, testing in the field of vaccines and medicines; Research and development in the field of cell therapies; Testing of pharmaceuticals for cell and gene therapies

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 9, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMerck KGaA
Party Type10 - Original Applicant
Legal Entity Type31 - NOT AVAILABLE
AddressDarmstadt 64293
DE

Trademark Events


Event DateEvent Description
Tuesday, December 9, 2025NEW APPLICATION ENTERED
Tuesday, December 9, 2025APPLICATION FILING RECEIPT MAILED
Thursday, February 12, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 26, 2026ASSIGNED TO EXAMINER
Tuesday, March 10, 2026APPROVED FOR PUB - PRINCIPAL REGISTER